Almirall, S.A.

Feb 22, 2021

Almirall's 2020 Full-Year Results

Feb 17, 2021

Almirall and MC2 Therapeutics enter a license, collaboration and commercialization agreement for European rights to Wynzora® Cream for treatment of plaque psoriasis

Feb 03, 2021

Almirall announces Gianfranco Nazzi as new CEO

Jan 07, 2021

Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies

Nov 24, 2020

Almirall announces collaborations with the University of South Australia and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Nov 09, 2020

Almirall demonstrates resilient performance year to date despite COVID-19 impacts

Oct 08, 2020

Almirall and the University of Dundee announce a multi-target research collaboration to develop novel Targeted Protein Degraders medicines